Alkermes Plc
NASDAQ:ALKS
Alkermes Plc
Gross Profit
Alkermes Plc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Alkermes Plc
NASDAQ:ALKS
|
Gross Profit
$1.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Gross Profit
$176.5m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
24%
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alkermes Plc's Gross Profit?
Gross Profit
1.5B
USD
Based on the financial report for Mar 31, 2024, Alkermes Plc's Gross Profit amounts to 1.5B USD.
What is Alkermes Plc's Gross Profit growth rate?
Gross Profit CAGR 10Y
14%
Over the last year, the Gross Profit growth was 64%. The average annual Gross Profit growth rates for Alkermes Plc have been 19% over the past three years , 10% over the past five years , and 14% over the past ten years .